Lyophilization is a prevalent technique for preparing
paclitaxel
(PTX) clinical formulations. However, the instability of PTX nanoparticles
poses challenges in producing lyophilized formulations. Such an instability
involves maintaining stable dispersions and structural integrity during
lyophilization. To tackle these issues, flash nanoprecipitation method
is employed to prepare highly stable and loaded lyophilizable diPTX-SS
nanoparticles, achieving over a month of nanosuspension stability
and 91 wt % loading capacity. Furthermore, adjusting the concentrations
and stabilizer ratios allows for controlled nanoparticle preparation
with surface structures suitable for lyophilization. The hybridization
of PLGA-PEG and DSPE-PEG increases the surface PEG layer content,
creating a corona-like outer layer that maintains nanoparticle integrity
during lyophilization, and ensures excellent redispersibility for
postlyophilization without excessive cryoprotectants. Additionally,
responsive release behavior, along with in vitro and in vivo experiments,
confirms that these lyophilizable hybrid diPTX-SS nanoparticles effectively
suppress tumor growth and vascular endothelial proliferation, offering
insights for clinical PTX formulation development.